Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
8
×
startups
8
×
boston blog main
new york blog main
boston top stories
cancer
deals
san francisco blog main
new york top stories
san diego blog main
san diego top stories
clinical trials
san francisco top stories
venture capital
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
fda
generic drugs
indiana blog main
indiana top stories
investing
ipo
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
takeda pharmaceutical
texas blog main
texas top stories
vc
wisconsin blog main
wisconsin top stories
What
drugs
8
×
new
bio
medicines
roundup
advance
aims
biology
cytokine
enhanced
pharmaceutical
research
san
suite
synthetic
synthorx
therapeutics
adding
ago
ahead
aiming
appetite
approach
asco
backed
bails
balance
based
biologic
biotech
black
brand
branded
bread
bridgebio
build
butter
buyout
called
cancer
Language
unset
Current search:
startups
×
drugs
×
" national top stories "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs